A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

Amin Al Olama, Ali, Kote-Jarai, Zsofia, Schumacher, Fredrick R, Wiklund, Fredrik, Berndt, Sonja I, Benlloch, Sara, Giles, Graham G, Severi, Gianluca, Neal, David E, Hamdy, Freddie C, Donovan, Jenny L, Hunter, David J, Henderson, Brian E, Thun, Michael J, Gaziano, Michael, Giovannucci, Edward L, Siddiq, Afshan, Travis, Ruth C, Cox, David G, Canzian, Federico, Riboli, Elio, Key, Timothy J, Andriole, Gerald, Albanes, Demetrius, Hayes, Richard B, Schleutker, Johanna, Auvinen, Anssi, Tammela, Teuvo L J, Weischer, Maren, Stanford, Janet L, Ostrander, Elaine A, Cybulski, Cezary, Lubinski, Jan, Thibodeau, Stephen N, Schaid, Daniel J, Sorensen, Karina D, Batra, Jyotsna, Clements, Judith A, Chambers, Suzanne, Aitken, Joanne, Gardiner, Robert A, Maier, Christiane, Vogel, Walther, Dörk, Thilo, Brenner, Hermann, Habuchi, Tomonori, Ingles, Sue, John, Esther M, Dickinson, Joanne L, Cooper, Colin S and , UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology (2013) A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics, 22 (2). pp. 408-415. ISSN 0964-6906

Full text not available from this repository. (Request a copy)

Abstract

Genome-wide association studies (GWAS) have identified multiple common genetic variants associated with an increased risk of prostate cancer (PrCa), but these explain less than one-third of the heritability. To identify further susceptibility alleles, we conducted a meta-analysis of four GWAS including 5953 cases of aggressive PrCa and 11 463 controls (men without PrCa). We computed association tests for approximately 2.6 million SNPs and followed up the most significant SNPs by genotyping 49 121 samples in 29 studies through the international PRACTICAL and BPC3 consortia. We not only confirmed the association of a PrCa susceptibility locus, rs11672691 on chromosome 19, but also showed an association with aggressive PrCa [odds ratio = 1.12 (95% confidence interval 1.03-1.21), P = 1.4 × 10(-8)]. This report describes a genetic variant which is associated with aggressive PrCa, which is a type of PrCa associated with a poorer prognosis.

Item Type: Article
Uncontrolled Keywords: case-control studies,disease progression,genetic predisposition to disease,genome-wide association study,humans,male,odds ratio,polymorphism, single nucleotide,prostatic neoplasms,quantitative trait loci,reproducibility of results
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 06 Jan 2014 14:56
Last Modified: 13 Sep 2018 10:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/46119
DOI: 10.1093/hmg/dds425

Actions (login required)

View Item